Questions & explanations
1. Compare top-down and bottom-up mass spectrometry approaches for protein analysis.
Bottom-up MS digests proteins into peptides before analysis, which is simpler and more sensitive for identifying proteins and modifications. However, it loses information about combinations of modifications on the same protein. Top-down MS analyzes intact proteins without digestion, preserving the full sequence and modification pattern. Top-down can identify proteoforms (different modified versions of a protein) but requires more advanced instrumentation and is less sensitive for large proteins. Bottom-up is more common for discovery proteomics, while top-down is better for characterizing specific protein variants. Both approaches are complementary.
2. How do regulations for synthetic biology products differ from those for traditional chemical products?
Synthetic biology products involve living organisms, which can grow, reproduce, and change over time. Traditional chemicals are stable and do not multiply. Therefore, regulations for synthetic biology focus on whether the organism can survive in the environment, transfer genes to other organisms, or cause unexpected effects. For chemicals, the main concern is toxicity and exposure. For example, a synthetic bacterium that cleans up oil spills must be tested for its ability to spread and its impact on local ecosystems. Chemical dispersants are tested for toxicity to marine life. The rules are adapted to the unique risks of living products.
3. Why is seamless cloning important for protein engineering libraries?
Seamless cloning ensures that no extra base pairs are added between protein domains or between a gene and its regulatory elements. Extra base pairs could cause frameshifts or introduce unwanted amino acids, which might disrupt protein structure or function. In combinatorial libraries, every variant must be correctly fused to express a functional protein. Seamless methods like Golden Gate and Gibson assembly maintain the reading frame and native sequences. This is critical for screening libraries where even small changes can affect activity. Without seamless cloning, many library members would be non-functional due to cloning artifacts.
4. Compare Golden Gate and Gibson assembly: which method is better for assembling many different DNA parts in one reaction, and why?
Golden Gate assembly is better for assembling many different parts in one reaction because it uses type IIS enzymes that generate unique overhangs, allowing multiple fragments to be assembled in a defined order. Gibson assembly can also join multiple fragments but requires overlapping ends that must be designed carefully; the efficiency drops with more fragments. Golden Gate reactions are typically faster (cycling between restriction and ligation) and can be more modular. For combinatorial libraries where many variants are needed, Golden Gate is often preferred. However, Gibson assembly is simpler for joining a few large fragments.
5. Why do different countries have different regulations for synthetic biology?
Countries have different laws because of their unique histories, cultures, and priorities. For example, the European Union has strict rules on genetically modified organisms (GMOs) due to public concern, while the United States regulates based on the product's use rather than the process. In India, the rules are influenced by the country's agricultural needs and biodiversity. Also, a country's scientific capacity and economic goals affect how much they encourage or restrict synthetic biology. International trade can be complicated when a product is approved in one country but not another. Harmonizing rules is an ongoing challenge.
6. Compare yeast two-hybrid with co-immunoprecipitation (co-IP) for studying protein interactions.
Y2H detects direct binary interactions in yeast, while co-IP detects interactions in cell lysates, which may be indirect (via other proteins). Y2H is high-throughput and can screen libraries, but interactions occur in yeast, which may not reflect the native environment. Co-IP uses native or tagged proteins in mammalian cells, preserving post-translational modifications and complexes. However, co-IP requires antibodies and may miss weak or transient interactions. Y2H can identify novel partners, but has higher false-positive rates. Both methods are complementary; Y2H is good for discovery, co-IP for validation in relevant cells.
7. Give an example of how you would use Golden Gate assembly to create a library of antibody variants with different complementarity-determining regions (CDRs).
You would design DNA fragments encoding each CDR variant with flanking type IIS restriction sites that produce unique overhangs. For example, a CDR1 fragment might have overhang A on one end and B on the other, while the vector backbone has overhangs A and B as well. Mix all CDR fragments and the backbone in one tube with the type IIS enzyme and ligase. The enzyme cuts and releases fragments with defined overhangs, which then ligate into the backbone in the correct order. By using many CDR variants, you generate a library of antibodies with different CDR combinations. This method ensures seamless junctions and high efficiency.
8. Compare DNA aptamers and antibodies as recognition elements in biosensors.
Both DNA aptamers and antibodies bind specifically to targets, but they differ in key ways. Aptamers are nucleic acids, while antibodies are proteins. Aptamers are smaller, more stable at high temperatures, and cheaper to produce chemically. Antibodies are larger and require living cells to make, so they cost more. Aptamers can be made for toxic or non-immunogenic targets, whereas antibodies need an immune response. However, antibodies often have higher binding affinity and are well-established in many tests. In biosensors, aptamers allow easier regeneration and longer shelf life, while antibodies provide proven performance.
9. Compare the use of 16S rRNA gene sequencing vs. whole-genome shotgun sequencing in metagenomics.
16S rRNA gene sequencing targets a specific gene found in all bacteria and archaea. It is cheaper and faster, giving a picture of which species are present and their relative abundance. However, it provides limited functional information. Whole-genome shotgun sequencing sequences all DNA in the sample, including genes from all organisms. It can reveal the functional potential, such as genes for antibiotic resistance or metabolism, and can identify viruses and eukaryotes. But it is more expensive and requires more complex data analysis. The choice depends on whether the goal is taxonomic profiling or functional insight.
10. What is next-generation sequencing (NGS) for metagenomics?
Next-generation sequencing (NGS) is a technology that reads millions of DNA fragments at once, quickly and cheaply. In metagenomics, it is used to sequence all the DNA extracted directly from an environmental sample, like soil or water, without needing to grow microbes in the lab. This reveals the genetic material of all organisms present, including bacteria, viruses, and fungi. NGS platforms, such as Illumina, produce short reads that are then assembled or compared to databases to identify species and their functions. It helps study microbial diversity in environments like oceans, human gut, or contaminated sites.
11. What is a DNA aptamer?
A DNA aptamer is a short, single-stranded DNA molecule that can bind tightly to a specific target, like a protein or small molecule. It is made in a lab through a process called SELEX, where many random DNA sequences are tested to find one that sticks to the target. Aptamers work like antibodies but are cheaper to produce and more stable. They are used in biosensors to detect toxins, pathogens, or disease markers. For example, an aptamer that binds to a cancer protein can be attached to a sensor to signal its presence. Unlike antibodies, aptamers can be made for toxic targets and can be reused after denaturation.
12. Why is it important to measure both affinity and kinetics of a protein-protein interaction, rather than just affinity?
Affinity (KD) tells you the strength of binding at equilibrium, but kinetics (kon and koff) reveal how quickly the interaction forms and breaks. Two interactions can have the same KD but very different kinetics. For example, a fast-on/fast-off interaction may be less effective in a biological context than a slow-on/slow-off one. In drug development, a slow dissociation rate (koff) often correlates with longer drug residence time and better efficacy. Kinetics can also indicate conformational changes or multiple binding steps. Therefore, measuring both provides a deeper understanding of the interaction mechanism.